[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"IR Centers\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100578026","embolization-for-the-treatment-of-heel-pain-secondary-to-plantar-fasciitis-100578026",false,"NCT06805942","Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis","Inclusion Criteria:Participants aged 22 years or older. Diagnosed with plantar fasciitis by an orthopedic or podiatry surgeon.\n\nUltrasound evaluation showing:\n\nIncreased plantar fascia thickness \\> 4 mm. Hyperemia in the plantar fascia near its proximal insertion or perifascial soft tissue.\n\nSelf-reported pain of at least 5\u002F10 on the Visual Analog Scale (VAS). Negative X-ray for acute fractures. Refractory to at least 6 weeks of conservative therapies. Able to provide written informed consent. -\n\nExclusion Criteria:Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis.\n\nCorticosteroid injection in the plantar fascia within 90 days prior to embolization.\n\nPrior surgical repair or plantar fascia rupture. Severe allergy to Lipiodol or iodinated contrast media. Diagnosis of peripheral arterial disease affecting the lower extremities. Active workers' compensation claim for plantar fasciitis. Pregnancy or breastfeeding. Type 1 Diabetes Mellitus or significant renal dysfunction (GFR \\\u003C 45 or serum creatinine \\> 2.0 mg\u002FdL).\n\nSensory or motor neuropathy of the feet. Active skin wounds on the plantar surface of the affected foot.\n\n\\-","ALL","22 Years","100 Years",{"count":19,"type":20},10,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.",[26],"Plantar Fasciitis of Both Feet","RECRUITING","2025-01-31",{"date":30,"type":31},"2025-02-03","ACTUAL",{"date":33,"type":20},"2025-02-15",{"date":35,"type":20},"2025-09-30",{"name":37,"class":38},"IR Centers","OTHER",""]